bims-pideca Biomed News
on Class IA PI3K signalling in development and cancer
Issue of 2026–09–27
fifteen papers selected by
Ralitsa Radostinova Madsen, MRC-PPU



  1. Lab Invest. 2026 Sep 22. pii: S0023-6837(26)00098-X. [Epub ahead of print] 106168
       PURPOSE: Lymphatic malformations (LMs) are rare, slow-flow vascular malformations often driven by somatic PIK3CA mutations. However, the role of PIK3CA mutations in the pathogenesis of LMs is not yet fully understood. In this study, we conducted an integrated analysis of LMs to clarify how PIK3CA mutations relate to clinical presentation, histopathological features, and molecular characteristics.
    MATERIALS AND METHODS: We retrospectively analyzed 34 LM cases. PIK3CA mutations were assessed using targeted next-generation sequencing with a custom gene panel. We also evaluated clinical and histopathological findings and performed immunohistochemistry. Spatial transcriptomics was performed on two PIK3CA-mutant LM cases.
    RESULTS: Somatic PIK3CA mutations were identified in 20/34 patients (58.8%). Clinical variables (age, sex, and lesion location) and most histopathological parameters were comparable between mutant and non-mutant LMs, although mutant LMs more often exhibited a scattered growth pattern of malformed vessels. The malformed vessel microenvironment, including fibrous stroma, lymphoid aggregates, and macrophages, was commonly observed regardless of the mutational status. Immunohistochemistry showed higher PI3K/AKT/mTOR pathway activation in the lymphatic endothelial cells (LECs) in LMs than in normal lymphatic vessels, independent of PIK3CA status, although this pathway is commonly activated by gain-of-function PIK3CA mutations. Phosphorylated AKT levels in LMs significantly increased with age. Spatial transcriptomics identified upregulation of 10 genes in LEC-containing regions of PIK3CA-mutant LMs. Among the upregulated genes, NFATC1, which regulates embryonic lymphangiogenesis, was highly expressed in LM LECs, suggesting that the calcineurin-NFAT pathway may contribute to LM pathogenesis.
    CONCLUSIONS: Overall, LMs share key pathogenic features irrespective of mutational status. This detailed analysis, focusing on LECs and the microenvironment, may offer insights into the mechanisms underlying LM pathogenesis and its implications for targeted therapies.
    Keywords:  PIK3CA; VEGFR3; lymphatic malformation; mTOR; sirolimus; vascular malformation
    DOI:  https://doi.org/10.1016/j.labinv.2026.106168
  2. Cell Syst. 2026 Sep 23. pii: S2405-4712(26)00219-X. [Epub ahead of print] 101737
      The use of CRISPR-associated enzymes in induced pluripotent stem cell (iPSC)-derived neurons presents unique challenges compared with dividing cell lines. For example, loss of dCas9-KRAB expression after differentiation has been observed and largely ascribed to transgene silencing. Here, we investigated the expression of CRISPR enzymes in iPSCs and Ngn2-derived neurons. We found that the commonly used dCas9-KRAB(KOX1) displayed a dramatic reduction in protein levels following differentiation, yet nCas9 constructs retained comparable levels. We further found that CRISPR constructs, primarily relying on the SV40 nuclear localization signal (NLS), fail to localize to the nuclei of neurons, despite having robust nuclear levels in iPSCs, leading to KRAB(KOX1)-specific cytoplasmic degradation. By testing other NLSs, we rescued neuronal nuclear localization and protein expression, confirming the contribution of mislocalization to the instability of dCas9-KRAB(KOX1) in neurons. As the lack of nuclear localization can have a profound impact on CRISPR activity, we suggest further investigation across cultured and in vivo postmitotic cell models. A record of this paper's transparent peer review process is included in the supplemental information.
    Keywords:  CRISPR; CRISPR screens; iPSC derived neurons
    DOI:  https://doi.org/10.1016/j.cels.2026.101737
  3. Acta Pharm Sin B. 2026 Sep;16(9): 5884-5900
      Hotspot mutations in phosphoinositide 3-kinase alpha (PI3Kα), such as H1047R, E542K, and E545K, drive tumorigenesis across multiple cancer types. Orthosteric PI3Kα inhibitors are effective but have toxicity against wild-type PI3Kα, the emergence of resistance, and a narrow therapeutic index. Allosteric inhibitors such as RLY-2608 and STX-478 offer a promising path toward mutant-specific suppression, yet the structural basis for their selectivity and mechanisms of action remain elusive. Here, we report high-resolution cryogenic electron microscopy structures of RLY-2608- and STX-478-bound H1047R, E542K, and E545K, revealing a shared cryptic allosteric pocket, accessible only through a major conformational rearrangement of the activation loop that is stabilized in oncogenic mutants. While both inhibitors occupy this pocket, they have distinct interaction networks and propagate divergent allosteric activities: RLY-2608 induces large-scale remodeling of catalytic and membrane-interacting elements, whereas STX-478 reinforces autoinhibitory interfaces between p110α and p85α subunits. Comparative analysis provides structural insights into their differentiated potency and selectivity.
    Keywords:  Cancer; Inhibitor; Mutation; PI3Kα; Selectivity
    DOI:  https://doi.org/10.1016/j.apsb.2026.07.003
  4. Nature. 2026 Sep 23.
      Mechanistic target of rapamycin complex 1 (mTORC1) senses nutrient availability to orchestrate metabolic processes that are crucial for physiological homeostasis and ageing1. mTORC1 preferentially regulates the translation of 5'-terminal oligopyrimidine (TOP) motif-containing mRNAs (which encode mainly ribosomal proteins) through the 4E-BP translational repressor2; however, this function of mTORC1 is resistant to rapamycin inhibition3. TOP mRNAs are exceptionally abundant, and thus impose a major translational burden on cells, but how their translation is physiologically tuned and linked with lifespan remains unclear. Here we show that Lsp2, which was previously known to be a storage protein4, is also an adipose effector and feedback activator of mTORC1 that modulates lifespan in Drosophila. Expression of Lsp2 is induced by essential amino acids through mTORC1 and is gated by additional signals of nutrient sufficiency. Genetic ablation of Lsp2 robustly extends lifespan without impairing key life history traits such as reproduction. Translatomic profiling shows that loss of Lsp2 selectively reduces global TOP mRNA translation in a 4E-BP-dependent manner, thereby extending lifespan through a mechanism distinct from the effects of rapamycin. Evolutionarily, TOP motifs co-emerged with 4E-BP and are present in nearly all Drosophila ribosomal protein mRNAs. Moreover, we show that the role of TOP motifs in translational control extends to Drosophila. Collectively, our findings reveal a nutrient-induced physiological factor that amplifies mTORC1 output in TOP mRNA translation and regulates organismal longevity.
    DOI:  https://doi.org/10.1038/s41586-026-11029-x
  5. Nature. 2026 Sep 23.
      Tuberous sclerosis complex (TSC) is a genetic neurodevelopmental disorder characterized by focal brain malformations called cortical tubers, which are associated with severe, intractable epilepsy1. Tubers are thought to result from somatic second-hit mutations that disrupt the TSC1 or TSC2 genes in neural progenitor cells, driving hyperactive mTORC1 signalling2. Glial abnormalities are commonly observed in tubers3; however, whether glia actively cause disease or merely result from chronic seizure activity has remained unclear. To address this question, we used human brain organoid models to track the developmental fate of mutated progenitor cells in the absence of seizures. Here we show, using single-cell transcriptomics and cyclic immunostaining across human brain organoids and resected tuber tissue from patients, that loss of TSC2 biases neural progenitors to differentiate into enlarged, pro-inflammatory reactive astrocytes in a cell autonomous manner. These mutant astrocytes show downregulated glutamate transporter expression, increased inflammatory cytokine secretion and elevated expression of neurodegenerative disease risk genes such as APOE and CLU. Our findings demonstrate that reactive astrocytes emerge as a primary consequence of TSC2 loss. These results implicate glial dysfunction as a driver of TSC pathogenesis and highlight reactive astrocytes as potential therapeutic targets for TSC-related neuropathology.
    DOI:  https://doi.org/10.1038/s41586-026-11054-w
  6. Acta Pharm Sin B. 2026 Sep;16(9): 6296-6298
      
    Keywords:  Allosteric inhibitor; Conformational dynamics; Cryo-EM; Oncogenic mutation; PI3Kα
    DOI:  https://doi.org/10.1016/j.apsb.2026.08.014
  7. Nat Cell Biol. 2026 Sep 24.
      Recent sequencing advances have enabled abundant multi-omics data generation for both single-cell and spatial contexts. Integrating such multimodal data is critical for decoding cellular and tissue-level complexity. However, compared with single-modality profiling, multimodal data often exhibit higher levels of noise, and existing methods typically overlook this challenge during integration. Meanwhile, most current approaches are tailored to either single-cell or spatial data, limiting their applicability across data types. Here we present DePass, a scalable graph learning framework for paired data integration in both single-cell and spatial multi-omics. We propose a coupled enhancement-integration architecture that iteratively denoises data and improves integrated embeddings. We systematically benchmarked DePass across 6 modalities, 9 tissue types and 13 experimental platforms, demonstrating superior integration accuracy. In the in-house colorectal cancer data, DePass further uncovered immune niche substructure and spatial tumour heterogeneity at near single-cell resolution. These results establish DePass as a unified and generalizable solution for multi-omics integration across diverse biological contexts.
    DOI:  https://doi.org/10.1038/s41556-026-02067-8
  8. Sci Adv. 2026 Sep 25. 12(39): eaee1905
      The mechanistic target of rapamycin complex 1 (mTORC1) integrates nutrient and hormonal cues to regulate hepatic lipid metabolism with major implications for metabolic dysfunction-associated steatotic liver disease (MASLD). Here, we show that altered hepatic mTORC1-TFEB/TFE3 signaling is associated with coordinated remodeling of bile acid (BA) metabolism during metabolic adaptation. Our data support a model in which cross-talk between mTORC1 and TFEB/TFE3 is associated with divergent regulation of bile acid synthesis and transformation. Depending on the mTORC1 signaling state, changes in hepatic Cyp2c70 and Cyp8b1 expression, together with altered cholesterol trafficking, were associated with shifts toward non-12-OH or 12-OH bile acid species. These effects were attenuated or reversed by Tfe3 deletion or rapamycin treatment. Furthermore, protein restriction (which inhibits mTORC1) similarly reshaped the BA profile in mice and correlated with improved metabolic outcomes in MASLD patients. Together, these findings uncover BA homeostasis as an integral component of the metabolic adaptations orchestrated by mTORC1, underscoring a link between nutrient signaling and metabolic liver disease.
    DOI:  https://doi.org/10.1126/sciadv.aee1905
  9. Biology (Basel). 2026 Sep 18. pii: 1650. [Epub ahead of print]15(18):
      Hemodynamic shear stress is a critical mechanical determinant of endothelial homeostasis, yet the mechanosensitive pathways governing metabolic reprogramming remain incompletely understood. Apolipoprotein A-I binding protein (AIBP) regulates cholesterol metabolism, but its role in endothelial mechanotransduction is unknown. Here, we investigated how shear stress modulates AIBP expression to direct human brain microvascular endothelial cell (HBMEC) function via vascular endothelial growth factor (VEGF)-dependent glycolytic reprogramming. HBMECs were subjected to laminar shear stress (1 Pa) with or without the mechanosensitive channel inhibitor GsMTx4. We utilized loss-of-function approaches (shRNA targeting AIBP and VEGF), metabolic assays (metabolite quantification, Western blotting of glycolytic enzymes), and functional assays (EdU proliferation, Transwell migration, tube formation, and apoptosis analysis). Laminar shear stress significantly downregulated AIBP levels via mechanosensitive channel activation. Downregulation or genetic silencing of AIBP stabilized HIF-1α, relieving constitutive repression of VEGF and activating downstream Akt and ERK1/2 signaling. This axis drove glycolytic reprogramming-evidenced by coordinated upregulation of GLUT1, HK2, PFK-A, PKM2, PTBP1, and LDHA, and accumulation of L(+)-lactate and pyruvate-which enhanced proliferation, migration, and tube formation while attenuating apoptosis. Pharmacological inhibition with GsMTx4 prevented shear-induced AIBP downregulation and subsequent metabolic activation. Crucially, simultaneous knockdown of VEGF abolished the glycolytic and phenotypic shifts induced by AIBP deficiency. AIBP functions as a novel mechanosensitive effector in endothelial cells. Shear stress-induced, channel-dependent downregulation of AIBP orchestrates endothelial activation strictly through VEGF-mediated glycolytic reprogramming, identifying a key mechano-metabolic coupling mechanism in vascular regulation.
    Keywords:  AIBP; VEGF; endothelial cells; glycolysis; shear stress
    DOI:  https://doi.org/10.3390/biology15181650
  10. Nat Commun. 2026 Aug 24. pii: 10101. [Epub ahead of print]17(1):
      Protein synthesis must be tightly coordinated with quality control to prevent proteotoxic stress, yet the mechanisms underlying co-translational surveillance in plants, and how these are aligned with translational output, remain poorly understood. Here, we identify three NOT4-like E3 ubiquitin ligases in Arabidopsis thaliana as regulators of co-translational protein quality control and uncover a functional link between NOT4 and TARGET OF RAPAMYCIN (TOR) signalling that coordinates quality-control capacity with translational output. Loss of NOT4 function increases basal TOR activity and global translation rates, resulting in the accumulation of polyubiquitylated proteins and heightened sensitivity to proteasome inhibition, TOR inhibition, and protein misfolding stress. Consistent with prior evidence that NOT4 proteins are TOR-regulated phosphotargets, not4 mutants also phenocopy TOR-inhibited wild-type plants for a subset of transcriptional and growth-related processes. Furthermore, elevated translation in NOT4-deficient plants enhances resistance to Pseudomonas syringae pv. tomato. Collectively, our findings reveal a functional coupling between TOR signalling and NOT4 activity that may scale quality control with translational demand to safeguard proteome homoeostasis across eukaryotes.
    DOI:  https://doi.org/10.1038/s41467-026-77200-0
  11. Immunity. 2026 Sep 22. pii: S1074-7613(26)00349-3. [Epub ahead of print]
      Environmental allergens are enriched in protease activity, which activates cutaneous sensory neurons, triggering itch and substance P release to promote migration of T helper (Th)2 cell-skewing CD301b+ dendritic cells and initiate allergic immunity. However, allergens are typically encountered through repeated subthreshold exposures, and how these cumulatively induce sensitization is unknown. We identified a sensory neuron-intrinsic mechanism of neuroimmune memory. Protease allergen exposure induced sustained mechanistic target of rapamycin complex 1 (mTORC1) kinase signaling and transcriptional activator peroxisome proliferator-activated receptor gamma coactivator-1α (PGC-1α)-associated mitochondrial remodeling in sensory neurons, establishing a metabolically primed state with enhanced neuronal responsiveness. Upon allergen re-exposure, this state drove enhanced itch, CD301b+ dendritic cell migration, and Th2 cell differentiation. Disrupting neuronal mTORC1 signaling or mitochondrial stability abrogated this amplification while sparing primary responses. This mechanism generalized across distinct protease allergens, revealing mTORC1-driven metabolic reprogramming in sensory neurons as a form of innate neuroimmune memory underlying allergen cross-sensitization and polysensitization.
    Keywords:  Th2 differentiation; allergy; cross-sensitization; dendritic cells; itch; mTORC1; metabolism; neuroimmune memory; neuroimmunology; sensory neurons
    DOI:  https://doi.org/10.1016/j.immuni.2026.08.012
  12. Science. 2026 09 24. 393(6818): eadw8520
      Mechanisms by which primary tumor cells acquire metastatic capability through metabolic and signaling adaptations are currently poorly understood. We demonstrate that tumor-intrinsic ceramide metabolism, amplified by dietary fat, initiates colorectal cancer metastasis. We observed that dietary fat exposure triggers a sustained increase in de novo ceramide biosynthesis, mediated by the dihydroceramide desaturase Degs1. Ceramide accumulation activates yes-associated protein (YAP) through protein phosphatase 2A (PP2A)-mediated dephosphorylation, promoting a durable shift toward a distinct YAP-driven regenerative (YAP-DR) program, marked by Basp1, that promotes metastasis. Selective elimination of Basp1high cancer cells prevented metastatic seeding. Degs1 loss reduced ceramide levels, YAP activity, YAP-DR signatures, and metastasis without affecting primary tumor growth, whereas blocking ceramide degradation enhanced YAP activity and metastasis. These findings identify ceramide-induced YAP signaling as a key mediator of metastatic initiation, operating independently of primary tumor expansion.
    DOI:  https://doi.org/10.1126/science.adw8520
  13. bioRxiv. 2026 Sep 14. pii: 2026.09.11.748700. [Epub ahead of print]
    Tabula Sapiens Consortium
      Alternative splicing greatly expands the diversity of gene products encoded by the human genome. Single-cell transcriptomic atlases have characterized human cell types through gene-level expression, but short-read sequencing has limited the ability to resolve full-length isoforms and their functional consequences. Here, we present a cross-tissue single-cell long-read isoform atlas spanning 26 human tissues. We identify hundreds of thousands of novel isoforms along with their cell-type-specific usage, and discover that over one-third of expressed isoforms are absent from existing reference databases. We further demonstrate that isoform usage is a structured, measurable axis of cellular identity that is distinct from gene expression. Applying this framework to cellular senescence, we resolve p16 INK4a and p14 ARF transcripts from the CDKN2A locus in individual cells and uncover cell-type-dependent isoform remodeling associated with the p16 INK4a senescence program. This isoform-resolved single-cell atlas offers a versatile framework to dissect the cellular logic of isoform regulation in senescence and beyond.
    DOI:  https://doi.org/10.64898/2026.09.11.748700
  14. Nat Commun. 2026 Aug 22. pii: 10043. [Epub ahead of print]17(1):
      Sex differences in cancers arising in non-reproductive organs are widespread. While sex hormones and the intrinsic sexual identity of cancer cells are well-established contributors, it is unknown whether other mechanisms are involved. Here, we reveal an unexpected source of sex-biased cancer vulnerability in a Drosophila model of tumorigenesis. By combining genetically induced tumours with tissue- and cell type-specific sex reversals, we show that sex differences in oncogenesis can arise independently of both gonadal hormone signalling and the sexual identity of tumour cells themselves. Unexpectedly, we find that a sexually dimorphic neuronal circuit, classically associated with mating behaviour, is both necessary and sufficient to drive sex-biased intestinal tumorigenesis. The sex of these gut-innervating neurons controls tumour growth by stimulating local production of an insulin-like growth factor in the visceral muscles, a key component of the intestinal stem cell niche. Our findings reveal a previously unrecognised class of tumour-promoting input: the sex of central neurons can reprogram peripheral tumour-supportive environments. Under physiological conditions, this brain-gut pathway also modulates stem cell activity and organ size in a sex-specific manner to promote reproduction. Our work opens a new line of inquiry into how neuronal sex, particularly within the brain-gut axis, shapes physiology and disease, a field still predominantly studied in a male-only context.
    DOI:  https://doi.org/10.1038/s41467-026-76998-z
  15. Front Cell Dev Biol. 2026 ;14 1900624
      Single-cell perturbation technologies, multimodal omics, spatial profiling, and generative modeling are transforming the virtual cell from a theoretical concept into a practical objective for cell biology. Yet current efforts often emphasize model scale, data volume, or predictive breadth, while the trustworthiness required for scientific and translational use remains insufficiently addressed. We argue that virtual-cell models become decision-relevant only when the evidential chain connecting data, model design, benchmarking, and experimental validation is made explicit. We introduce the trustworthy virtual cell, a perturbation-resolved, context-aware, and experimentally validated system capable of supporting biological inference, experimental design, and preclinical decision-making. We organize recent progress around four empirical layers, namely, molecular cell state, intervention, biological context, and orthogonal phenotype, complemented by structured priors. This framework explains why static atlases, transcriptome-only readouts, and in-distribution benchmarks are insufficient for predicting cellular behavior under new conditions. Across mechanistic, deep generative, foundation, and hybrid models, we discuss trade-offs among interpretability, scalability, and extrapolation. We further argue that evaluation should move beyond held-out reconstruction accuracy toward biologically meaningful criteria, including generalization to unseen cell types and perturbations, dose, time, and combination response extrapolation, uncertainty calibration, and mechanistic consistency. We then propose a closed-loop validation ladder connecting in silico predictions to CRISPR perturbation, imaging, organoid, and tissue-level assays. Our aim is to review what current models can and cannot yet do, and to set out an evidential framework specifying what a virtual cell must demonstrate before its outputs are acted upon, noting which requirements are attainable today and which remain longer-term goals.
    Keywords:  model validation; multimodal integration; single-cell perturbations; trustworthy AI; virtual cells
    DOI:  https://doi.org/10.3389/fcell.2026.1900624